The ACC/AHA 2021 Chest Pain Assessment Guidelines boosted coronary computed tomography angiography (CCTA) to a Class 1A level of clinical evidence and helped significantly boost interest in building or expanding cardiac CT programs in the past year. While Cardiac CTA does have a large amount of clinical study support, there are some gaps remaining yet...

Private equity investors have started getting more involved in cardiology in recent years, echoing their rise in radiology, dermatology and other specialties.

The integration of artificial intelligence into radiology PACS and enterprise imaging systems has become a big topic of discussion with IT vendors over the past couple years. This has become a bigger question from hospitals and radiology groups as there are now about 400 radiology related AI algorithms that have U.S. Food and Drug Administration...

Risk model-based screening for lung cancer accounting for personal risk may be more cost-effective than age- and smoking history-based screening recommended by the U.S. Preventive Services Task Force (USPSTF), according to a cost-effectiveness analysis.

Radiotherapy after breast-conserving surgery can be safely omitted in certain older women with low-risk, hormone receptor-positive early breast cancer receiving adjuvant endocrine therapy, 10-year results of the PRIME II trial showed.

Two years after hospitalisation for severe COVID-19 illness, more than a third of patients from the pandemic’s early days had lingering pulmonary abnormalities on chest CT scans, according to a prospective study from Wuhan, China.

Text-generating AI models, such as ChatGPT, have the potential to “revolutionise the field of medical writing” by automating tasks and increasing efficiency throughout the writing process.

An AI tool named “Sybil” was able to forecast both short- and long-term lung cancer risk based on a single low-dose CT (LDCT) scan, researchers reported.

Adding docetaxel to radiation therapy improved survival outcomes in cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase III randomised trial showed.

In efforts to speed workflow, improve patient care and augment an increasingly shorthanded clinical workforce, AI is starting to see wider adoption across healthcare. But there are questions regarding who is liable if an AI application fails and it results in a malpractice lawsuit.